News Roche hopes blood test will predict immunotherapy efficacy Test could help determine which patients respond to immunotherapies.
News Public trusts supermarkets more than pharma - poll Swiss company looks move on from Tamiflu scandal
News Roche’s Alecensa shows big benefit in brain mets, advanced l... Roche’s Alecensa has shown strong results in two studies looking at its benefits in ALK positive non-small cell lung cancer (NSCLC) patients, both in first line use and a second line setting.
News Boehringer to develop fibrosis treatment with Inventiva Boehringer to progress R&D partnership that began last year
News FDA grants fast review for Roche's haemophilia drug Emicizumab is firm's latest blockbuster hopeful
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.